Ivabradin Aristo

Ivabradine, the active ingredient in Ivabradin Aristo, is a If channel inhibitor presented as an oral tablet for oral use. It lowers heart rate and is employed in the management of chronic stable angina and certain forms of heart failure.

GNH USA supplies Ivabradin Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivabradin Aristo acts on the cardiac If current to control heart rate in specific cardiovascular conditions.

Chronic stable angina: reduces the frequency of angina attacks by lowering heart rate in patients with documented coronary artery disease. Heart failure: improves symptoms and may decrease hospitalisations in patients with reduced ejection fraction by maintaining a controlled heart rate.

Ivabradin Aristo may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Visual disturbances (phosphenes or luminous phenomena) - Bradycardia (slow heart rate) - Headache - Dizziness - Fatigue - Nausea

Serious or Rare Side Effects: - Symptomatic atrial fibrillation - Severe bradycardia requiring medical intervention - Hypotension with syncope - Persistent visual impairment - Heart block of any degree - Allergic reactions such as rash or angioedema

Before prescribing Ivabradin Aristo, clinicians should evaluate cardiovascular status and concomitant medications.

Assess baseline heart rate: ensure resting rate is ≥70